{"url_path":"/sec/indp/8-k/2026-06-05/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1857044/0001493152-26-027499-index.html","accession_number":"0001493152-26-027499","cik":"0001857044","ticker":"INDP","issuer_name":"Indaptus Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1857044/0001493152-26-027499-index.html","primary_entity_key":"0001857044","primary_entity_name":"Indaptus Therapeutics, Inc."},"word_count":164,"has_tables":true,"body_markdown":"**Item\n5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of\nCertain Officers.**\n\n \n\n**Resignation\nof Directors and Officer**\n\n \n\nEffective\nas of June 5, 2026, Mr. David E. Lazar and Mr. Avraham Ben-Tzvi resigned from all directorship positions, including\nfrom all committees served, on the Board of Directors (the “*Board*”) of Indaptus Therapeutics, Inc. (the “*Company*”).\n\n \n\nEffective\nas of June 1, 2026, Mr. Walt A. Linscott, Esq. resigned as the Chief Operating Officer of the Company, and, pursuant to a consulting\nagreement with the Company dated June 1, 2026, will serve as a consultant for the Company.\n\n \n\nMr. Lazar’s,\nMr. Ben-Tzvi’s and Mr. Linscott’s resignation was not a result of any disagreement with the Company on any matter\nrelating to its operations, policies or practices. The Board wishes to thank Mr. Lazar and Mr. Ben-Tzvi for their services\nand contributions to the Company, and looks forward to continuing to work with Mr. Linscott in his strategic advisory\nrole."}